Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules (RABITO)
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules
Sponsor: Amsterdam UMC
Terminated
Switched from RCT to observational prospective cohort due to termination of subsidy (delay due to insufficient inclusion-rate). Follow-up of RCT-arm will be completed. Patients can still be included in a observational cohort.
A PHASE3 clinical study on Autonomous Thyroid Function and Iodine Adverse Reaction, this trial is terminated or withdrawn. The trial is conducted by Amsterdam UMC and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Aug 2025 — Sep 2025 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Sep 2024 — Aug 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
May 2023 — May 2024 [monthly]
Recruiting PHASE3
-
Mar 2022 — May 2023 [monthly]
Recruiting PHASE3
-
Jan 2022 — Mar 2022 [monthly]
Recruiting PHASE3
First recorded
Nov 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC
- Rijnstate Hospital
- University of Twente
- ZonMw: The Netherlands Organisation for Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .